Startseite Growth patterns in pubertal HIV-infected adolescents and their correlation with cytokines, IGF-1, IGFBP-1, and IGFBP-3
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Growth patterns in pubertal HIV-infected adolescents and their correlation with cytokines, IGF-1, IGFBP-1, and IGFBP-3

  • Marion Kessler EMAIL logo , Aditya Kaul , Claritsa Santos-Malavé , William Borkowsky , Jason Kessler und Bina Shah
Veröffentlicht/Copyright: 20. Juni 2012
Journal of Pediatric Endocrinology and Metabolism
Aus der Zeitschrift Journal of Pediatric Endocrinology and Metabolism Band 26 Heft 7-8

Abstract

Objective: This study aims to describe the final adult height (FAH) and pubertal growth patterns in human immunodeficiency virus (HIV)-infected adolescents and to compare these to an age-matched population of seroreverting HIV-exposed, uninfected (HEU) adolescents. It further aims to evaluate the interplay of proinflammatory cytokines with insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3), and IGFBP-1 during the pubertal growth spurt.

Methods: HIV-infected (n=34) and HEU (n=12) adolescents who had achieved FAH were evaluated. Auxologic data, viral load, CD4+ T-lymphocyte (CD4) count, and the use of highly active antiretroviral therapy were obtained via a retrospective chart review. Serum interleukin (IL)-1α, IL-6, tumor necrosis factor (TNF)-α, IGFBP-1, IGFBP-3, and IGF-1 were assessed.

Results: The mean FAH standard deviation score for the HIV-infected group was –0.78 (±1.1) compared to 0.05 (±0.78) for the HEU (p=0.034). There was a positive correlation between CD4 count and FAH (p=0.019). The mean age and magnitude of peak growth velocity (GV) was within normal limits. IL-1α, IL-6, TNF-α, IGFBP-3, and IGF-1 were not significantly correlated with HIV RNA or height. IGFBP-1 was detectable in 100% of poorly controlled HIV-infected patients and 25% of the HEU cohort (p=0.0003).

Conclusions: The FAH of HIV-infected patients was significantly shorter than that of HEU patients, and it positively correlated with CD4 count. Our cohort demonstrated normal timing and magnitude of peak GV during puberty.

Keywords: cytokines; growth; growth hormone resistance; human immunodeficiency virus (HIV); insulin-like growth factor binding protein 1 (IGFBP-1)
Corresponding author: Marion Kessler, MD, Diabetes and Endocrine Center for Children and Young Adults, 755 North Broadway, Suite 400 Sleepy Hollow, New York, NY 10591, USA Phone: +1-917-208-1623, Fax: +1-914-366-3407

This work was supported in part by grant 1UL1RR029893 from the National Center for Research Resources, National Institutes of Health.

References

1. Arpadi S. Growth failure in children with HIV infection. J Acquir Immune Defic Syndr 2000; 25(Suppl 1):S37–42.10.1097/00126334-200010001-00006Suche in Google Scholar

2. Gertner JM, Kaufman FR, Donfield SM, Sleeper LA, Shapiro AD, et al. Delayed somatic growth and pubertal development in human immunodeficiency infected hemophiliac boys: Hemophilia Growth and Development Study. J Pediatr 1994;124:896–902.10.1016/S0022-3476(05)83177-4Suche in Google Scholar

3. Stagi S, Galli L, Chiappini E, Losi S, Gattinara CG, et al. Final height in patients perinatally infected with the human immunodeficiency virus. Horm Res Paediatr 2010;74:165–71.10.1159/000281018Suche in Google Scholar

4. Guillén S, Ramos JT, Resino R, Bellón JM, Muñoz MA. Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J 2007;26:334–8.10.1097/01.inf.0000257427.19764.ffSuche in Google Scholar

5. Nachman SA, Lindsey JC, Pelton S, Mofenson L, McIntosh K, et al. Growth in human immunodeficiency infected children receiving Ritonovir-containing antiretroviral therapy. Arch Pediatr Adolesc Med 2002;156:497–503.10.1001/archpedi.156.5.497Suche in Google Scholar

6. Spencer RP. Pubertal height gain, male-female and interpopulation comparisons. Med Hypotheses 2002;59:759–61.10.1016/S0306-9877(02)00326-2Suche in Google Scholar

7. Vizmanos B, Marti-Hennenberg C. Age of pubertal onset affects the intensity and duration of pubertal growth peak, but not final height. Am J Hum Biol 2001;13:409–16.10.1002/ajhb.1065Suche in Google Scholar PubMed

8. Buchacz K, Rogol AD, Lindsey JC, Wilson CM, Hughes MD, et al. Delayed onset of pubertal development of children and adolescents with perinatally acquired HIV infection. J Acquir Immune Defic Syndr 2003;33:56–65.10.1097/00126334-200305010-00009Suche in Google Scholar PubMed

9. Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls relation to body mass index and race. Pediatrics 2001;108:347–53.10.1542/peds.108.2.347Suche in Google Scholar PubMed

10. Chantry CJ, Hughes MD, Alvero C, Cervia JS, Hodge J, et al. Insulin-like growth factor-1 and lean body mass in HIV-infected children. J Acquir Immune Defic Syndr 2008;48:437–43.10.1097/QAI.0b013e31817bbe6dSuche in Google Scholar PubMed

11. Samstein B, Hoimes ML, Fan J, Frost RA, Gelato MC, et al. IL-6 stimulation of insulin-like growth factor binding protein (IGFBP-1) production. Biochem Biophys Res Commun 1996;228:611–5.10.1006/bbrc.1996.1705Suche in Google Scholar PubMed

12. Lang C, Nystrom GJ, Frost RA. Regulation of IGF binding protein-1 in Hep G2 cells by cytokines and reactive oxygen species. Am J Physiol 1999;276:G719–26.10.1152/ajpgi.1999.276.3.G719Suche in Google Scholar PubMed

13. Holt R, Baker A, Jones J, Miell J. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation. Pediatr Transplant 1998;2:76–84.Suche in Google Scholar

14. Davies UM, Jones J, Reeve J, Camacho-Hubner C, Charlett A, et al. Juvenile rheumatoid arthritis: effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin. Arthritis Rheum 1997;40:332–40.10.1002/art.1780400218Suche in Google Scholar PubMed

15. De Benedetti F, Meazza C, Martini A. Role of interleukin-6 in growth failure: an animal model. Horm Res 2002;58:24–7.10.1159/000064757Suche in Google Scholar PubMed

16. World Health Organization (http://www.who.int/en/). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children; c2007. Available from www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf. Accessed 30 March, 2009.Suche in Google Scholar

17. Rogol A, Clark P, Roemmich JN. Growth and pubertal development in children and adolescents: effects of diet and physical activity. Am J Clin Nutr 2000;72:521S–8S.10.1093/ajcn/72.2.521SSuche in Google Scholar PubMed

18. Susman E, Houts R, Steinberg L, Belsky J, Cauffman E, et al. Longitudinal development of secondary sexual characteristics of boys and girls between 9½ and 15½ years. Arch Pediatric Adolesc Med 2010;164:166–73.10.1001/archpediatrics.2009.261Suche in Google Scholar PubMed PubMed Central

19. de Martino M, Tovo PA, Galli L, Gabiano C, Chiarelli F, et al. Puberty in perinatal HIV infection: a multicentre longitudinal study of 212 children. AIDS 2001;15:1527–34.10.1097/00002030-200108170-00010Suche in Google Scholar PubMed

20. Marshall WA, Tanner JM. Variation in pattern of pubertal patterns in boys. Arch Dis Child 1970;45:13–23.10.1136/adc.45.239.13Suche in Google Scholar PubMed PubMed Central

Received: 2011-11-30
Accepted: 2012-3-21
Published Online: 2012-06-20
Published in Print: 2013-08-01

©2013 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorials
  4. Editorial
  5. Precocious puberty and diagnostic tests
  6. Review article
  7. The influence of carbohydrate quality on cardiovascular disease, the metabolic syndrome, type 2 diabetes, and obesity – an overview
  8. Original Articles
  9. Triptorelin depot stimulation test for central precocious puberty
  10. Umbilical cord and fifth-day serum vaspin concentrations in small-, appropriate-, and large-for-gestational age neonates
  11. Growth patterns in pubertal HIV-infected adolescents and their correlation with cytokines, IGF-1, IGFBP-1, and IGFBP-3
  12. Estrogen receptor α gene analysis in girls with central precocious puberty
  13. Trends of body composition among adolescents according to maturation stage and body mass index
  14. Oxidized low-density lipoprotein levels and carotid intima-media thickness as markers of early atherosclerosis in prepubertal obese children
  15. Interaction of bone mineral density, adipokines and hormones in obese adolescents girls submitted in an interdisciplinary therapy
  16. The contribution of art therapy in poorly controlled youth with type 1 diabetes mellitus
  17. NOX, the main regulator in oxidative stress in experimental models of phenylketonuria?
  18. Changes in growth pattern, leptin ghrelin and neuropeptide Y levels after adenotonsillectomy in prepubertal children
  19. Impact of inborn errors of metabolism on admission in a neonatal intensive care unit: a 4-year report
  20. Correlation between bone mineral density measured by peripheral and central dual energy X-ray absorptiometry in healthy Indian children and adolescents aged 10–18 years
  21. Thyroid-stimulating hormone (TSH) level in nutritionally obese children and metabolic co-morbidity
  22. Hepatocyte growth factor as an indicator of neonatal maturity
  23. Pathophysiology of critical illness hyperglycemia in children
  24. The influence of exposure to maternal diabetes in utero on the rate of decline in β-cell function among youth with diabetes
  25. Clinical and molecular characterization of Chilean patients with Léri-Weill dyschondrosteosis
  26. Abdominal aorta intima media thickness in obese children
  27. Patient reports
  28. KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child
  29. Hoffmann’s syndrome and pituitary hyperplasia in an adolescent secondary to Hashimoto thyroiditis
  30. Late diagnosis of Cushing’s disease in a child: what lessons can be learned?1)
  31. Variable phenotype in five patients with Wolcott-Rallison syndrome due to the same EIF2AK3 (c.1259delA) mutation
  32. Recurrent infantile hypoglycemia due to combined fructose-1,6-diphosphatase deficiency and growth hormone deficiency
  33. A previously undescribed mutation detected by sequence analysis of CYP21A2 gene in an infant with salt wasting congenital adrenal hyperplasia
  34. Transient neonatal hyperparathyroidism: a presenting feature of sialidosis type II
  35. Effect of recombinant insulin-like growth factor-1 treatment on short-term linear growth in a child with Majewski osteodysplastic primordial dwarfism type II and hepatic insufficiency
  36. Duplication of dosage sensitive sex reversal area in a 46, XY patient with normal sex determining region of Y causing complete sex reversal
  37. The search for ectopic ACTH production in a 9-year-old boy
  38. Development of antibodies against growth hormone (GH) during rhGH therapy in a girl with idiopathic GH deficiency: a case report
  39. Ovotesticular disorder of sexual development and a rare 46,XX/47,XXY karyotype
  40. Brachydactyly mental retardation syndrome in differential diagnosis of pseudopseudohypoparathyroidism
  41. Letters to the Editors
  42. How much truth is there in the association between endometriosis and atherosclerosis?
  43. Delayed cord clamping in plethoric term neonates of diabetic mothers: friend or foe?
  44. Meetings
  45. Meetings Calendar
https://doi.org/10.1515/jpem-2011-0464
Schlagwörter für diesen Artikel
cytokines; growth; growth hormone resistance; human immunodeficiency virus (HIV); insulin-like growth factor binding protein 1 (IGFBP-1)

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorials
  4. Editorial
  5. Precocious puberty and diagnostic tests
  6. Review article
  7. The influence of carbohydrate quality on cardiovascular disease, the metabolic syndrome, type 2 diabetes, and obesity – an overview
  8. Original Articles
  9. Triptorelin depot stimulation test for central precocious puberty
  10. Umbilical cord and fifth-day serum vaspin concentrations in small-, appropriate-, and large-for-gestational age neonates
  11. Growth patterns in pubertal HIV-infected adolescents and their correlation with cytokines, IGF-1, IGFBP-1, and IGFBP-3
  12. Estrogen receptor α gene analysis in girls with central precocious puberty
  13. Trends of body composition among adolescents according to maturation stage and body mass index
  14. Oxidized low-density lipoprotein levels and carotid intima-media thickness as markers of early atherosclerosis in prepubertal obese children
  15. Interaction of bone mineral density, adipokines and hormones in obese adolescents girls submitted in an interdisciplinary therapy
  16. The contribution of art therapy in poorly controlled youth with type 1 diabetes mellitus
  17. NOX, the main regulator in oxidative stress in experimental models of phenylketonuria?
  18. Changes in growth pattern, leptin ghrelin and neuropeptide Y levels after adenotonsillectomy in prepubertal children
  19. Impact of inborn errors of metabolism on admission in a neonatal intensive care unit: a 4-year report
  20. Correlation between bone mineral density measured by peripheral and central dual energy X-ray absorptiometry in healthy Indian children and adolescents aged 10–18 years
  21. Thyroid-stimulating hormone (TSH) level in nutritionally obese children and metabolic co-morbidity
  22. Hepatocyte growth factor as an indicator of neonatal maturity
  23. Pathophysiology of critical illness hyperglycemia in children
  24. The influence of exposure to maternal diabetes in utero on the rate of decline in β-cell function among youth with diabetes
  25. Clinical and molecular characterization of Chilean patients with Léri-Weill dyschondrosteosis
  26. Abdominal aorta intima media thickness in obese children
  27. Patient reports
  28. KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child
  29. Hoffmann’s syndrome and pituitary hyperplasia in an adolescent secondary to Hashimoto thyroiditis
  30. Late diagnosis of Cushing’s disease in a child: what lessons can be learned?1)
  31. Variable phenotype in five patients with Wolcott-Rallison syndrome due to the same EIF2AK3 (c.1259delA) mutation
  32. Recurrent infantile hypoglycemia due to combined fructose-1,6-diphosphatase deficiency and growth hormone deficiency
  33. A previously undescribed mutation detected by sequence analysis of CYP21A2 gene in an infant with salt wasting congenital adrenal hyperplasia
  34. Transient neonatal hyperparathyroidism: a presenting feature of sialidosis type II
  35. Effect of recombinant insulin-like growth factor-1 treatment on short-term linear growth in a child with Majewski osteodysplastic primordial dwarfism type II and hepatic insufficiency
  36. Duplication of dosage sensitive sex reversal area in a 46, XY patient with normal sex determining region of Y causing complete sex reversal
  37. The search for ectopic ACTH production in a 9-year-old boy
  38. Development of antibodies against growth hormone (GH) during rhGH therapy in a girl with idiopathic GH deficiency: a case report
  39. Ovotesticular disorder of sexual development and a rare 46,XX/47,XXY karyotype
  40. Brachydactyly mental retardation syndrome in differential diagnosis of pseudopseudohypoparathyroidism
  41. Letters to the Editors
  42. How much truth is there in the association between endometriosis and atherosclerosis?
  43. Delayed cord clamping in plethoric term neonates of diabetic mothers: friend or foe?
  44. Meetings
  45. Meetings Calendar
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 1.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2011-0464/html
Button zum nach oben scrollen